Search Within

Sloan Kettering Institute Postdocs

  1. "Massachusetts Medical Society"
Formats
  1. Journal Article (10)
  2. Research Letter (2)
Groups
  1. Department of Medicine (10)
  2. Center for Hematologic Malignancies (7)
  3. GSK Faculty (7)
  4. Survivorship Research (7)
  5. Epidemiology and Biostatistics (6)
  6. Hematologic Malignancies, Division of (6)

More Groups

People
  1. Jae Park (4)
  2. Andrea Cercek Hanjis (3)
  3. Benoit Rousseau (3)
  4. Gunjan Shah (3)
  5. Luis Diaz (3)
  6. Sean Devlin (3)

More People

Years
  1. 2025 (2)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (1)
  5. 2018 (1)
  6. 2015 (2)

More Years

Publications
  1. New England Journal of Medicine (12)
Publishers
  1. Massachusetts Medical Society (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The duration of immunotherapy for mismatch repair-deficient cancers
    Research Letter

    Rousseau, B.; White, J. R.; Cercek, A.; Diaz, L. A. Jr
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer
    Journal Article

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Lamendola-Essel, M.; El Dika, I. H.; Segal, N.; Shcherba, M.; Sugarman, R.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Mechanisms of resistance to noncovalent Bruton's tyrosine kinase inhibitors
    Journal Article

    Wang, E.; Mi, X.; Thompson, M. C.; Montoya, S.; Notti, R. Q.; Afaghani, J.; Durham, B. H.; Penson, A.; Witkowski, M. T.; Lu, S. X.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • The spectrum of benefit from checkpoint blockade in hypermutated tumors
    Research Letter

    Rousseau, B.; Foote, M. B.; Maron, S. B.; Diplas, B. H.; Lu, S.; Argilés, G.; Cercek, A.; Diaz, L. A. Jr
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation
    Journal Article

    Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Slingerland, A. E.; Slingerland, J. B.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Classification and personalized prognosis in myeloproliferative neoplasms
    Journal Article

    Grinfeld, J.; Nangalia, J.; Baxter, E. J.; Wedge, D. C.; Angelopoulos, N.; Cantrill, R.; Godfrey, A. L.; Papaemmanuil, E.; Gundem, G.; MacLean, C.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Ibrutinib in previously treated Waldenström's macroglobulinemia
    Journal Article

    Treon, S. P.; Tripsas, C. K.; Meid, K.; Warren, D.; Varma, G.; Green, R. ; Argyropoulos, K. V.; Yang, G.; Cao, Y.; Xu, L.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save